Evidence map›Paper›PMID 40740066›Full record

ReviewNanomedicine (London, England)2025

Bioengineered nanoparticles for targeted topical delivery in wound healing: advances and future outlook.

Ankita Sood, Vaidehi Patwardhan, Sudipta Nayak, Srinidhi Chintalapani, Sachin Mandal, Kulbhushan Tikoo

Abstract readReview
In one paragraph

Review in Nanomedicine (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Biofilm-Responsive Nanoplatforms for Infected Wound Reconstruction.International journal of nanomedicine · 2026
    Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ankita SoodLaboratory of Epigenetics and Diseases, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India.
Vaidehi PatwardhanLaboratory of Epigenetics and Diseases, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India.
Sudipta NayakLaboratory of Epigenetics and Diseases, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India.
Srinidhi ChintalapaniLaboratory of Epigenetics and Diseases, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India.
Sachin MandalLaboratory of Epigenetics and Diseases, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India.
Kulbhushan TikooLaboratory of Epigenetics and Diseases, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The convergence of nanoscale engineering and biomimetics is revolutionizing wound care by enabling the development of bioengineered nanoparticles with exceptional therapeutic precision. This review synthesizes recent advances in nanoparticle-based interventions that mimic biological systems for targeted, controlled, and stage-specific wound healing. Innovations covered include receptor-specific ligand conjugation, bioactive scaffolds, nucleic acid-based systems, microenvironment-responsive nanomaterials, stimuli-activated metal nanoparticles, biosensing platforms, and exosome-mimicking systems. These approaches offer enhanced modulation of the wound microenvironment and promote tissue regeneration, addressing major drawbacks of conventional therapies. Therapeutic efficacy is critically evaluated using data from recent in vitro and in vivo studies. A structured literature search was conducted using PubMed, Scopus, Web of Science, and ScienceDirect, covering publications from January 2015 to June 2025. Relevant studies were selected based on their focus on nanoparticle-based wound-healing strategies, bioengineering innovations, and translational potential. The review also discusses challenges such as biocompatibility, biodistribution, manufacturing scalability, and regulatory hurdles that limit clinical adoption. Finally, this review explores the future paradigm of personalized nanotherapeutics, tailored to individual patient pathophysiology. By summarizing current developments and forecasting future directions, this review highlights the transformative role of bioengineered nanoparticles in next-generation wound healing and regenerative medicine.

Indexed as

Drug Delivery SystemsNanoparticlesWound HealingAdministration, TopicalAnimalsBioengineeringHumansBioengineered nanoparticlesbiomimeticsmicroenvironment-responsive systemsnanomedicinestimuli-activated nanoparticleswound healing

Identifiers

PMID40740066
PMCPMC12330261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.